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Enteric viruses, including poliovirus and reovirus,
encounter a vast microbial community in the
mammalian gastrointestinal tract, which has been
shown to promote virus replication and pathogen-
esis. Investigating the underlying mechanisms, we
find that poliovirus binds bacterial surface polysac-
charides, which enhances virion stability and cell
attachment by increasing binding to the viral recep-
tor. Additionally, we identified a poliovirus mutant,
VP1-T99K, with reduced lipopolysaccharide (LPS)
binding. Although T99K and WT poliovirus cell
attachment, replication, and pathogenesis in mice
are equivalent, VP1-T99K poliovirus was unstable in
feces following peroral inoculation of mice. Conse-
quently, the ratio of mutant virus in feces is reduced
following additional cycles of infection in mice. Thus,
the mutant virus incurs a fitness cost when environ-
mental stability is a factor. These data suggest that
poliovirus binds bacterial surface polysaccharides,
enhancing cell attachment and environmental stabil-
ity, potentially promoting transmission to a new host.
INTRODUCTION
The gastrointestinal tract contains a diverse community of
microbes, which play an essential role in host health. Imbalances
in this microbial community have been linked to many human
diseases, including inflammatory bowel disease, diabetes, and
obesity (Manichanh et al., 2012; Tremaroli and Ba¨ckhed, 2012).
While many studies have focused on bacterial-host interactions
in the gastrointestinal tract, the impact of the microbiota on
viruses is less clear.
Enteric viruses are a significant cause of disease worldwide
and are transmitted by direct contact, fomites, and contami-
nated water or food. While many enteric viruses cause asymp-
tomatic infection or mild symptoms, these viruses can cause
serious to life-threatening illnesses. Poliovirus is a nonenvel-
oped, single-stranded RNA virus in the Enterovirus genus of
the Picornaviridae. Until the development of vaccines in the
1950s, poliovirus was a major cause of paralysis. Spread by36 Cell Host & Microbe 15, 36–46, January 15, 2014 ª2014 Elsevier Ithe fecal-oral route, poliovirus can disseminate from the gastro-
intestinal tract and damage neurons.
Recent data suggest that intestinal microbiota enhance infec-
tion of three unrelated enteric viruses: poliovirus, reovirus, and
mouse mammary tumor virus (MMTV) (Kane et al., 2011; Kuss
et al., 2011). The retrovirus MMTV binds bacterial lipopolysac-
charide (LPS) and induces immune tolerance through a Toll-
like receptor 4-dependent mechanism (Kane et al., 2011).
Reovirus replication and pathogenesis were enhanced by intes-
tinal microbiota, although the mechanism is unknown (Kuss
et al., 2011). Similarly, poliovirus replication and pathogenesis
were enhanced by intestinal microbiota (Kuss et al., 2011). We
determined that exposure to bacteria increased infectivity of
poliovirus virions. After exposure to Gram-positive or Gram-
negative bacteria, we recovered up to 5-fold more plaque-form-
ing units (pfus) than we started with. Since only 1 of every 200
picornavirus particles is infectious, these data suggest that
exposure to bacteria ‘‘resurrects’’ infectivity for some particles,
reducing the particle:pfu ratio. However, the precise mecha-
nisms and consequences of bacterial effects on poliovirus are
unclear.
Here, we examined the mechanisms of bacterial-mediated
enhancement of poliovirus. We demonstrate a dual role for bac-
terial polysaccharide-mediated enhancement of poliovirus infec-
tivity through virion stability and cell attachment via the poliovirus
receptor (PVR). Notably, we identified a single amino acid
substitution in a viral capsid protein, VP1-T99K, which reduces
LPSbinding and limits virion stabilization by LPS.We determined
that VP1-T99K poliovirus replicates and is pathogenic in
perorally inoculated mice, but is unstable in feces. Our data
reveal that microbiota play a critical role in stabilizing viral parti-
cles in the environment and thus may promote transmission.RESULTS
Bacterial Surface Polysaccharides Enhance Poliovirus
Virion Stability
Previously we found that exposure of type 1 Mahoney poliovirus
to bacteria or bacterial surface polysaccharides reduced thermal
inactivation of viral particles at a variety of temperatures (Kuss
et al., 2011). To define the polysaccharide requirements for sta-
bilization, we examined thermal inactivation of poliovirus in the
presence of glycans. Poliovirus was incubated with various com-
pounds at 42C for 6 hr followed by quantification of viral titers bync.
Figure 1. Bacterial Surface Polysaccha-
rides Enhance Poliovirus Stability In Vitro
(A) GlcNAc-containing polysaccharides enhance
poliovirus stability. WT Mahoney poliovirus (1 3
106 pfu) was incubated with indicated compounds
(1 mg/ml) at 42C for 6 hr, followed by HeLa cell
plaque assay. Input poliovirus titers were set to
100%, and data are shown as percent of input
pfu. O, deacetylated chitin (chitosan); X, contains
sulfate groups (heparan); n = 5–9.
(B) Bacterial polysaccharides enhance viral re-
covery following bleach treatment. WT Mahoney
poliovirus was incubated with indicated com-
pounds (1 mg/ml) at 37C for 1 hr followed by
treatment with 0.1 mg/ml bleach for 1 min and
plaque assay; n = 5–8.
(C) Incubation with LPS limits virion inactivation
as measured by gradient virion density analysis.
35S-labeled poliovirus was incubated with PBS
or 1 mg/ml LPS at 42C for 1 hr prior to loading
on 10%–30% sucrose gradients. Gradients were
subjected to ultracentrifugation, and fractions
were collected from the top of the gradient and
scintillation counted. 160S, intact particles; 80S,
empty particles. Graph is representative of three
experiments.
(D) Poliovirus thermostability profile using a cell-
free Particle Stability Thermo Release assay
(PaSTRy). Virus was added to SYBR Green or
SYPRO Red and placed in a real-time PCR
machine. Samples were heated from 25C to 99C on a 1% stepwise gradient with florescence monitoring. Peaks correspond to RNA release (SYBR
Green) and capsid structural transitions (SYPRO Red). Graph is representative of three experiments.
(E) Quantification of PaSTRy experiments revealing GlcNAc polysaccharides enhance thermostability of poliovirus by preventing premature RNA release.
Poliovirus was incubated with indicated compounds at 37C for 1 hr prior to addition of SYBRGreen and analysis with a real-time PCRmachine; n = 3–9. See also
Figure S1. Data are mean ± SEM; *p < 0.05.
Cell Host & Microbe
LPS Enhancement of Poliovirus Stabilityplaque assay. We found that exposure to GlcNAc-containing
polysaccharides, including the bacterial surface polysaccha-
rides LPS and peptidoglycan (PG), enhanced stability of polio-
virus (Figure 1A; Kuss et al., 2011). Detoxified LPS lacking lipid
A also enhanced poliovirus stability, suggesting that the polysac-
charide component of LPS was sufficient for stabilization. Chitin,
a long polysaccharide containing only GlcNAc, stabilized
poliovirus. However, a six-unit GlcNAc oligosaccharide (chito-
hexaose) or monomeric GlcNAc did not stabilize poliovirus.
Similarly, poliovirus was not stabilized by deacetylated chitin
(chitosan) or a GlcNAc-containing polysaccharide with sulfate
groups (heparan). Therefore, viral stabilization required an acet-
ylated GlcNAc-containing polysaccharide longer than six units.
In addition to inactivation from heat, virus particles can be
inactivated by disinfectants such as chlorine bleach through
penetration of the viral capsid followed by RNA release and/or
damage (Alvarez and O’Brien, 1982; O’Brien and Newman,
1979; Sharp et al., 1975; Taylor and Butler, 1982). To examine
whether bacterial surface polysaccharides limit inactivation
from bleach treatment, we preincubated poliovirus with various
compounds for 1 hr, exposed them to 1 mg/L (0.001%) bleach
for 1 min, neutralized with sodium bisulfite, and quantified
viability by plaque assay. Viability of LPS and PG-exposed
viruses was over 1,000-fold higher than PBS- or control
glycan-exposed viruses (Figure 1B). These data suggest that
GlcNAc-containing polysaccharides enhance poliovirus stability
and increase bleach resistance of virions.Cell HPlaque formation is influenced by several factors in addition
to virion stability; therefore, we performed additional experi-
ments to examine virion stability using physical/cell-free
methods. First, we examined virion conformational changes
using sucrose gradients. Poliovirus undergoes irreversible
conformational changes that are part of the normal entry pro-
cess (Fricks and Hogle, 1990; Hogle and Racaniello, 2002;
Kaplan et al., 1990). Native virions (160S) transition to empty
capsids (80S) after RNA release. 160S-80S transitions can
also be triggered in solution by heating. Since bacterial polysac-
charides enhance poliovirus thermostability and bleach resis-
tance, we hypothesized that LPS exposure would limit the
160S-80S transition at elevated temperature. To test this,
35S-labeled poliovirus was incubated with LPS or PBS at 42C
for 1 hr and loaded on a sucrose gradient. Following ultracentri-
fugation, radioactivity from gradient fractions revealed that
polioviruses incubated with PBS were primarily 80S/empty
particles while polioviruses incubated with LPS were primarily
160S/native particles (Figure 1C).
As a second method to quantify virion stability using a
physical/cell-free approach, we examined whether LPS influ-
ences viral RNA release using a Particle Stability Thermal
Release assay (PaSTRy) (Walter et al., 2012). This calorimetry-
type assay has been used to measure stability of several picor-
naviruses (Plevka et al., 2013; Walter et al., 2012). Poliovirus
was preincubated with PBS, LPS, or mannan for 1 hr; solutions
were mixed with either SYBR Green (measures RNA release) orost & Microbe 15, 36–46, January 15, 2014 ª2014 Elsevier Inc. 37
Figure 2. Bacterial LPS Enhances Poliovirus Attachment to Its
Cellular Receptor, PVR
(A) LPS and PG enhance poliovirus cell attachment in a PVR-
dependent manner. Gradient purified 35S-labeled Mahoney poliovirus
was incubated ±1 mg/ml PG or LPS at 37C for 1 hr and added to cells
for 10 min (4C), followed by washing and scintillation counting of cell-
associated virus. As indicated, HeLa cells were incubated ±PVR anti-
body or an isotype control antibody (IgG1) for 1 hr prior to virus exposure;
n = 3–6.
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hydrophobic amino acids); and samples were heated in a
real-time PCR machine with fluorescence monitoring. PBS-
treated viruses generated a peak of fluorescence intensity for
both fluorophores indicating RNA release and initial capsid
denaturation at 46C, consistent with results from Walter et al.
(Walter et al., 2012) (Figures 1D and 1E). However, for LPS-
treated poliovirus the peak of SYBR Green fluorescence was
shifted to 49C (Figure 1D and see Figure S1 available online),
indicating that LPS exposure stabilized the capsid and delayed
RNA release. LPS-mediated stabilization of poliovirus was con-
centration dependent, as RNA release temperatures were
similar to PBS controls when poliovirus was incubated in
0.05mg/mL of LPS instead of 1 mg/ml LPS (Figure 1E). Mannan,
a control polysaccharide, did not enhance virion thermosta-
bility. Overall, these data indicate that exposure to GlcNAc-
containing bacterial polysaccharides enhanced viral stability
by limiting premature RNA release.
Bacterial Polysaccharides Enhance Poliovirus Cell
Attachment by Increasing Binding to the Viral
Receptor, PVR
Previously we determined that exposure of poliovirus to bacteria
enhanced cell attachment to PVR-expressing cells (Kuss et al.,
2011). To determine whether bacterial polysaccharides are
sufficient for the cell attachment enhancement, we examined
attachment of 35S-labeled poliovirus treated with or without
PG or LPS. We incubated 35S-labeled poliovirus with PBS or
1 mg/ml PG or LPS for 1 hr at 37C, incubated samples with
HeLa cells at 4C for 10min to facilitate binding, washed and har-
vested cells, and quantified cell-associated virus by scintillation
counting. We found that poliovirus preincubated with PG or LPS
demonstrated enhanced binding to HeLa cells when compared
to poliovirus preincubated with PBS (Figure 2A). To determine
whether PVR is required for the LPS-mediated enhancement of
poliovirus attachment, we examined poliovirus attachment to
HeLa cells treated with anti-PVR or isotype control antibody.
Treatment with anti-PVR antibody reduced poliovirus binding
to HeLa cells, regardless of whether virus was treated with
LPS, indicating that LPS-mediated attachment enhancement
is PVR dependent (Figure 2A). Furthermore, negligible amounts
of virus bound to non-PVR-expressing mouse L929 cells,
regardless of PBS or LPS pretreatment (Figure 2A). The
PG- and LPS-mediated enhancement of poliovirus attachment(B) Poliovirus binding to PVR. 35S-labeled poliovirus was incubated ±1 mg/ml
LPS for 1 hr at 37C followed by incubation with nitrocellulose membranes
containing immobilized PVR protein. After washing, bound viral CPMwas used
to quantify binding. Blot is representative of three experiments.
(C) Quantification of poliovirus-PVR binding assays. Binding was quantified by
phosphoimager analysis; n = 3.
(D) Differential LPS concentration requirements for poliovirus stabilization and
cell attachment enhancement. 35S-poliovirus was incubated with different
concentrations of LPS followed by HeLa cell attachment assay as described
above (gray dashed line, left axis). Unlabeled poliovirus was incubated with
different concentrations of LPS followed by thermal inactivation assay per-
formed at 42C for 6 hr (black line, right axis), and statistical analysis compares
data from each [LPS] to the 0 mg/ml LPS control; n = 3–10. Data are
mean ±SEM; *p < 0.05, compared with PBS control.
nc.
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nism involving PVR or an indirect mechanism. To determine
whether LPS-treated viruses have increased binding to PVR,
we examined viral binding to purified PVR. PVR protein was
immobilized on a nitrocellulose membrane and probed with
35S-labeled poliovirus preincubated with PBS or 1 mg/ml LPS.
We found that poliovirus preincubated with LPS had significantly
higher PVR binding when compared to poliovirus preincubated
with PBS (Figure 2BC). These data suggest that LPS enhances
binding of poliovirus to PVR. Therefore, the LPS-mediated
enhancement of poliovirus attachment to PVR-expressing cells
is likely to occur through a direct mechanism.
Given that our results suggest that two mechanisms, stability
and cell attachment, play a role in polysaccharide-mediated
viral infectivity enhancement, we wondered whether the two
mechanisms have similar polysaccharide concentration require-
ments. To test this, poliovirus was incubated with various con-
centrations of LPS and subjected to virion stability and cell
attachment assays. We found that maximal thermal stabilization
was achieved with 1 mg/ml LPS (Figure 2D). However, maximal
cell attachment enhancement was achieved with 0.05 mg/ml
LPS. Therefore, maximal enhancement of viral attachment
required 20-fold less LPS than maximal virion stabilization.
Since poliovirus virions contain 60 copies of each capsid
protein, there are up to 60 potential polysaccharide-binding
sites per virion. Our results suggest that virion stabilization
may require occupation of more binding sites than cell attach-
ment enhancement.
Identification of a Conditional Mutant, VP1-T99K, with
Reduced LPS Binding and Virion Stabilization at
Physiological Temperatures
GlcNAc-containing polysaccharides such as LPS directly
interact with the poliovirus capsid (Kuss et al., 2011); therefore,
it may be possible to identify viral mutants with reduced LPS
binding. We capitalized on the fact that many poliovirus capsid
mutants have been characterized. One famous poliovirus
mutant, the attenuated Sabin serotype 1 strain used in the oral
vaccine, contains 12 nonsynonymous mutations in the capsid-
coding region in addition to other mutations in the nonstructural
coding region (Figure 3A; Nomoto et al., 1982). Several of these
12 capsid mutations are in surface-exposed regions. To screen
for LPS effects on Sabin poliovirus, we examined virion stability
following 6 hr incubation at 37C. Initially, we used 37C rather
than 42C for these experiments since the Sabin strain is tem-
perature sensitive. While LPS enhanced stability of wild-type
poliovirus (virulent Mahoney, WT), LPS did not enhance stability
of Sabin poliovirus at 37C (Figure 3B). Moreover, Mahoney
poliovirus containing the Sabin VP1 capsid protein was not sta-
bilized by LPS exposure at 37C (Figure 3B, S-VP1). Site-
directed mutagenesis of the seven VP1 mutations identified
the residue at 99 (T99K) as critical for the LPS- and PG-mediated
stabilization at 37C (Figure 3B and Figure S2A). Amino acid 99 is
located in the highly exposed BC loop of VP1, near the 5-fold
symmetry axis (Figure 3C).
We next examined the temperature dependence of the T99K
phenotype by performing virion stability experiments at various
temperatures. To our surprise, T99K poliovirus was stabilized
by LPS or PG exposure when incubations were performed atCell H42C (Figure 3D and Figure S2B). To examine the precise
temperature requirements for LPS-mediated virion stabilization,
WT and T99K viruses were incubated with LPS at various
temperatures from 4C to 48C for 6 hr followed by plaque
assay. LPS treatment enhanced WT infectivity at every temper-
ature tested, when compared to PBS treatment (Figure 3E). In
contrast, LPS treatment only enhanced T99K viral infectivity at
temperatures above 40C (Figure 3F).
We hypothesized that T99K is a conditional mutant for LPS
binding and stabilization. In our model, the lysine at position 99
blocks polysaccharide binding to a nearby site at low tempera-
tures, but the binding site is open at high temperatures (see con-
ceptual model in Figures S2C–S2E). To test this, we deleted VP1
amino acid 99 in the Mahoney poliovirus strain and examined
stability in the presence or absence of LPS at 42C. The virus
lacking VP1 amino acid 99 (D99) was viable and was stabilized
by LPS at 42C (Figure 3D and Figure S2). These results demon-
strate that residue 99 is not the polysaccharide binding site but
influences binding.
Because LPS did not enhance T99K stability at physiological
temperatures (Figure 3B), we hypothesized that this mutant
has reduced LPS binding. To test this, 35S-labeled WT or
T99K virus was incubated with biotinylated LPS at 37C for
1 hr before precipitation with streptavidin beads. Binding of
biotinylated LPS to poliovirus was saturable (Figure 4A), and
binding was reversible since additon of excess nonbiotinylated
LPS limited binding to biotinylated LPS (Figure S3). While T99K
virus bound biotinylated LPS, binding was reduced compared
with WT virus (Figure 4A). Since enhancement of viral attach-
ment requires lower LPS concentrations than enhancement of
virion stability (Figure 2E), we wondered whether T99K virus
binds enough LPS to enhance cell attachment but not virion
stability. To examine cell attachment, WT and T99K viruses
were preincubated with 1 mg/ml LPS at 37C for 1 hr and
added to PVR-expressing HeLa cells. Preincubation with LPS
enhanced T99K cell attachment to the same degree as for
WT virus (Figure 4B). These data suggest that the T99K muta-
tion does not adversely affect LPS-mediated enhancement of
cell attachment but does impair LPS-mediated enhancement
of virion stability. In summary, the T99K virus is a conditional
mutant with reduced LPS-mediated virion stabilization at phys-
iological temperatures.
T99K and WT Poliovirus Replication and Pathogenesis
Are Equivalent
Since T99K poliovirus has reduced LPS binding, which reduces
LPS-mediated thermostability enhancement, but not LPS-medi-
ated cell attachment enhancement, we sought to use this virus
as a tool to dissect the mechanisms and consequences of
bacterial polysaccharide-mediated enhancement of poliovirus
infectivity in vivo. First, to rule out general growth defects, we
performed growth curves of WT and T99K viruses in HeLa cells.
Quantification of viral titers by plaque assay revealed no growth
defect of T99K compared with WT (Figure 5A).
Next, we perorally inoculated susceptible PVR-transgenic
(PVR) interferon a/b receptor knockout (IFNAR/) mice with
WT or T99K viruses and examined viral shedding in feces, repli-
cation, and pathogenesis (Ida-Hosonuma et al., 2005; Kuss
et al., 2011; Ohka et al., 2007). Mice were inoculated perorallyost & Microbe 15, 36–46, January 15, 2014 ª2014 Elsevier Inc. 39
Figure 3. Identification of a Conditional Poliovirus Mutant, VP1-T99K, with Altered LPS-Mediated Virion Stabilization
(A) Amino acid differences (circles) between the wild-type (WT) serotype 1 Mahoney poliovirus and Sabin poliovirus. Red circle represents VP1-99.
(B) LPS-mediated enhancement of viral stability is abrogated in Sabin and T99K polioviruses at 37C.WTMahoney, Sabin, and viral mutants were incubated with
1 mg/ml LPS at 37C for 6 hr, and titers were quantified by plaque assay; n = 3–11.
(C) Mahoney poliovirus structure with the location of VP1-99 highlighted in red. Arrows indicate 5-fold symmetry axes (8 of 12 are visible). The inset shows one
5-fold symmetry axis, and circles surround VP1-99.
(D) LPSstabilizesT99Kpoliovirus andD99poliovirus at high temperatures. Viruseswere incubatedwith 1mg/ml LPSat 42C for 6hr prior toplaque assay; n=5–11.
(E and F) Thermal stability profiles for WT versus T99K polioviruses. WT or T99K viruses were incubated in PBS or 1 mg/ml LPS at various temperatures for 6 hr
prior to plaque assay; n = 3–10. See also Figure S2. Data are mean ±SEM; *p < 0.05.
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in feces was approximately equivalent (Figure 5B). Since a high
amount of unreplicated inoculum virus is shed in the feces 1–
3 days after peroral inoculation, viral titers in the feces do
not necessarily reflect viral replication (Kuss et al., 2008). To
overcome this problem, we used light-sensitive viruses. Virus
propagated in the presence of neutral red dye is sensitive to
light-induced inactivation by RNA crosslinking but loses light
sensitivity upon replication, facilitating assessment of replication
and differentiating inoculum virus from replicated virus (Bran-40 Cell Host & Microbe 15, 36–46, January 15, 2014 ª2014 Elsevier Idenburg et al., 2007; Kuss et al., 2008; Kuss et al., 2011). Neutral
red-labeled WT and T99K viruses were used to perorally inocu-
late PVR-IFNAR/ mice in the dark, and feces were collected
in the dark. Virus was isolated from the feces and exposed to
either light or dark. Viral replication was quantified by deter-
mining the ratio of light- versus dark-exposed titers. At 24, 48,
and 72 hr postinoculation no difference in viral replication was
observed between WT and T99K viruses (Figure 5C). Finally,
we examined viral pathogenesis and found that mouse survival
was equivalent for both viruses (Figure 5D).nc.
Figure 4. The T99K Mutant Has Reduced LPS Binding but Intact
LPS-Mediated Cell Attachment Enhancement
(A) Biotinylated LPS-35S-poliovirus binding assay. 35S-labeled viruses were
incubated with biotinylated LPS or standard LPS for 1 hr at 37C followed by
precipitation with streptavidin beads. The % of virus bound was quantified by
scintillation counting; n = 3–6.
(B) T99K poliovirus cell attachment. 35S-labeled WT or T99K poliovirus was
incubated with PBS or 1mg/ml LPS at 37C for 1 hr and added to HeLa cells at
4C to facilitate viral binding. After washing, cell-associated radioactivity was
quantified; n = 5. See also Figure S3. Data are mean ±SEM; *p < 0.05.
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tion, and pathogenesis are similar to WT. These results were
not particularly surprising, considering that the only defect
observed for the T99K virus is lack of stabilization by bacterial
polysaccharides due to reduced LPS binding. Since poliovirus
initiates infection within 2–4 hr following peroral inoculation of
mice, and poliovirus is stable at 37C for 2–4 hr, virion stability
is not a major selective pressure in this infection system (Kuss
et al., 2008, 2011).
Microbiota Stabilize WT Virus but Not T99K Virus in
Feces, Revealing a Consequence for Viruses with
Reduced LPS Binding
Given that T99K poliovirus is not stabilized by bacterial poly-
saccharides at physiological temperatures, we hypothesized
that the T99K mutation may confer a fitness cost when selec-
tive pressure on virion stability is applied. This type of selectiveCell Hpressure happens routinely in nature, since virions must be
stable in the environment to initiate infection in a new host.
To examine environmental stability, we quantified the ratio of
WT to T99K viruses in mixtures exposed to various selective
pressures. To do this, we engineered a T99K mutant with a
silent mutation creating a new NheI site to distinguish it from
WT (Figure 6A). First, we examined stability of the T99K-NheI
virus in vitro to ensure that the virus was as stable as WT virus
in PBS. WT or T99K-NheI virus was mixed with PBS and incu-
bated at 22C for 5 days. Aliquots were removed at 0, 72, and
120 hr and quantified by plaque assay. Both WT and T99K-
NheI viruses experienced slow but equivalent inactivation
over time (Figure S4). These results also demonstrate that
T99K virions do not have an intrinsic stability defect in the
absence of bacteria. Second, T99K-NheI and WT viruses
were mixed 1:1 and incubated with PBS for 96 hr at 22C (Fig-
ure 6B). Viruses were amplified in HeLa cells until cytopathic
effects were observed, and RNA was isolated, reverse tran-
scribed, and amplified by PCR with a radioactive primer. Ampli-
fied RT-PCR products were digested with NheI and analyzed
by electrophoresis on an acrylamide gel. Following a 96 hr
incubation, the ratio of T99K:WT was similar to input suggest-
ing that the decay of both viruses was similar (Figure 6CD).
These results confirm that T99K virions do not have stability
defects in the absence of bacteria.
Finally, to examine environmental stability of WT versus T99K
viruses in a model mimicking natural transmission, we examined
the ratio of the two viruses in feces from perorally inoculated
mice. PVR-IFNAR/ mice were inoculated with a 1:1 mixture
of WT and T99K-NheI viruses. Fresh feces were collected at
6 hr postinoculation or left in the cage for 24 or 96 hr at room tem-
perature to impose environmental stability pressure (Figure 6E).
Feces were collected, fecal viruses were amplified in HeLa cells
to generate viral RNA, and RT-PCR NheI digestion products
were analyzed using an acrylamide gel. Samples from inoculum,
6 hr feces, or 24 hr feces revealed similar amounts of each virus
(Figures 6F and 6G). In contrast, samples collected from 96 hr
feces revealed significantly lower ratios of T99K:WT, indicating
that the T99K-NheI was not as stable as WT in the environment
(Figure 6FG). These results indicate that viruses with reduced
LPS binding and LPS-mediated stabilization incur a fitness
cost when environmental stability is a factor. It is possible that
even minor differences in transmission efficiency may have
major consequences over repeated transmission cycles due to
additive effects. To test this, we perorally inoculated primary
micewith a 1:1mixture ofWT and T99K-NheI viruses, aged feces
for 96 hr at room temperature, amplified fecal viruses in HeLa
cells to generate enough virus for secondary mouse inoculation,
perorally inoculated naive secondary mice, aged feces for 96 hr
at room temperature, and examined the ratio of T99K:WT virus at
each step (Figure 6H). As expected, samples from inoculum or
cell culture-passaged viruses revealed similar amounts of each
virus. However, T99K-NheI virus was reduced 2.6-fold in primary
mouse feces and 3.9-fold in secondary mouse feces, confirming
a fitness cost in the presence of selective pressure for virion
stability (Figure 6I). Overall, these data suggest that bacterial
polysaccharides bind poliovirus particles and protect them
from inactivation in the environment, potentially promoting
transmission to the next host.ost & Microbe 15, 36–46, January 15, 2014 ª2014 Elsevier Inc. 41
Figure 5. Viral Replication, Shedding, and Pathogenesis Are
Unaffected by the T99K Mutation
(A) T99K displays no in vitro growth defects compared to WT in growth curve
assays. HeLa cells were infected with WT or T99K poliovirus (moi 10) at 37C
and incubated at 2, 4, 8, and 16 hr postinfection followed by plaque assay;
n = 3–4.
(B) Fecal shedding kinetics of WT and T99K viruses. PVR-IFNAR/mice were
inoculated perorally with either WT or T99K poliovirus (1 3 108 pfu) and feces
were collected at 24, 48, and 72 hr postinoculation prior to plaque assay.
(C) In vivo replication of WT and T99K viruses. Neutral red/light-sensitive WT or
T99K poliovirus was used to perorally inoculate PVR-IFNAR/ mice in the
dark, and feces were collected at 24, 48, and 72 hr in the dark. Fecal virus was
isolated and either exposed to light or kept in the dark. Viral titers were
quantified and viral replication was determined by the ratio of light exposed
virus to dark virus.
(D) Survival of PVR-IFNAR/ mice following peroral inoculation with WT or
T99K poliovirus. Data in (B)–(D) are from two independent experiments
(18 mice per virus). In all panels, black lines indicate WT and gray dashed lines
indicate T99K. Data are mean ±SEM; *p < 0.05.
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Although microbiota-host interactions are widely studied, how
microbiota interact with viruses is relatively unclear. Previously
we found that microbiota enhance viral replication and patho-
genesis for two enteric viruses, poliovirus and reovirus (Kuss
et al., 2011). Here we examined mechanisms by which bacteria
enhance poliovirus virion infectivity, and we explored the conse-
quences for a mutant virus with reduced LPS binding.
First, we found that GlcNAc-containing bacterial surface poly-
saccharides, including LPS, bind poliovirus virions and stabilize
the particles by preventing premature RNA release. Poliovirus
exposed to LPS or PG was stable at elevated temperatures
and in the presence of dilute chlorine bleach (Figures 1A and
1B). Physical assays including density gradients and a calorim-
etry-type assay (PaSTRy) (Walter et al., 2012) demonstrated
that LPS exposure prevents premature RNA release (Figures
1C–1E). Interestingly, LPS exposure shifted the temperature of
RNA release by over 3C (Figures 1D and 1E and Figure S1).
This 3C shift is impressive considering that capsid-stabilizing
drugs that cause permanent virion stabilization and prevent
uncoating of enterovirus 71 also shift RNA release by 3C (Plevka
et al., 2013). Interestingly, the polysaccharide-mediated stabili-
zation could be a ‘‘double-edged sword,’’ as capsid plasticity
is needed for uncoating during infection. It is unknown how
polysaccharide-stabilized poliovirus retains the capsid flexibility
required for uncoating following PVR binding.
Second, we found that LPS aids poliovirus attachment to host
cells via a direct enhancement of binding to the viral receptor,
PVR. Clearly, poliovirus can bind its receptor in the absence of
LPS. However, LPS-bound viruses have enhanced PVR binding,
likely explaining their enhanced attachment to HeLa cells (Fig-
ure 2). Interestingly, we found that cell attachment enhancement
required significantly less LPS than virion stabilization (Fig-
ure 2D). Since each poliovirus virion contains 60 potential
binding sites, it is possible that stabilization requires binding of
several sites while cell attachment enhancement requires
binding of fewer sites. While the concentration of bacterial poly-
saccharide present in the gastrointestinal tract is difficult to
measure, it is likely to be in the milligrams/milliliters range
(Bates et al., 2007; Freudenberg et al., 1991). Therefore, thenc.
Figure 6. An Environmental Stability Defect for T99K Poliovirus
(A) Schematic of the T99K virus marked with a silent NheI site. An additional NheI site in both WT and T99K PCR products serves as an internal digestion control.
Star represents the 32P-labeled antisense primer location. For radioactive bands appearing on gels, undigested PCR products are 565 nt, NheI-digestedWT PCR
products are 465 nt, and NheI-digested T99K-Nhe PCR products are 170 nt.
(B) In vitro stability experiment design. WT and T99K-NheI viruses were mixed 1:1 and incubated with PBS for 96 hr at 22C. Virus was amplified in HeLa cells,
RNA was harvested, and RT-PCR products were digested with NheI.
(C) Representative gel of NheI-digested RT-PCR products to quantify the ratio of WT:T99K viruses from the in vitro stability experiment.
(D) Quantification of data from (C); n = 3.
(E) In vivo environmental stability experiment design. WT and T99K-NheI viruses were mixed 1:1, and PVR-IFNAR/mice were perorally inoculated with 23 107
pfu total. Mice were euthanized at 24 hr postinoculation. Feces were harvested at 6 hr or left in the cage bottom for 24 or 96 hr at 22C. Fecal viruses were
amplified in HeLa cells, RNA was harvested, and RT-PCR products were digested with NheI. Viruses passaged exclusively in tissue culture (TC) served as a
fitness control.
(F) Representative gel of NheI-digested RT-PCR products to quantify the ratio of WT:T99K viruses. Input, inoculum virus mixture.
(G) Quantification of data from (F); n = 3–5.
(H) In vivo environmental stability transmission experiment design. Performed as in (E), except that primary mouse feces were aged for 96 hr at 22C, followed by
amplification in HeLa cells, peroral inoculation of secondarymice, 96 hr 22C aging of secondarymouse feces, and analysis of virus ratios by digestion of RT-PCR
products with NheI.
(I) Quantification of data from (H). See also Figure S4. Data are mean ±SEM; *p < 0.05.
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rides needed for stabilization of virions and enhancement of
host cell attachment.
A major goal of this study was to identify a mutant virus with
reduced LPS binding and examine the consequences for viral
fitness. To that end, we found that VP1-T99K-containing poliovi-
ruses, including the attenuated serotype 1 Sabin vaccine strain,Cell Hhave reduced LPS binding at physiological temperature. Our
data suggest that while amino acid 99 is not the polysaccha-
ride-binding site, it influences binding. We hypothesize that K99
viruses are in a ‘‘closed’’ conformation at low/physiological tem-
peratures but that at high temperatures (>40C) the structure
‘‘opens’’ to reveal the polysaccharide-binding site (Figures
S2C–S2E). In agreementwith this hypothesis, we found that virusost & Microbe 15, 36–46, January 15, 2014 ª2014 Elsevier Inc. 43
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Interestingly, many fecal/sewage isolates from the K99-contain-
ing Sabin serotype 1 vaccine have T, N, R, E, S, or G at position
99, suggesting that lysine at this position may confer a selective
disadvantage (Kew et al., 1998, 2002; van der Sanden et al.,
2009; Yakovenko et al., 2006). Residue 99 is located on the BC
loop near the PVR binding site (Harber et al., 1995; He et al.,
2003; Moss and Racaniello, 1991). This region of VP1 is espe-
cially antigenic and variable among picornaviruses (Page et al.,
1988). In fact, the BC loop can be replaced and partially deleted
without eliminating viral viability (Liao and Racaniello, 1997). Our
data suggest that the selective pressure of environmental stabil-
ity may be one reason for the variation at residue 99 often
observed in environmental isolates of the Sabin vaccine.
Poliovirus is found in soil, sewage, drinking water, and shell-
fish, and virus remains infectious in the environment for varying
lengths of time (Hovi et al., 2001; Jaykus, 1997; Li et al., 1998;
Okoh et al., 2010; Tierney et al., 1977; Ward, 1977). Poliovirus
in the environment typically originates from humans infected
with circulating virulent poliovirus or the Sabin vaccine strains.
Acutely infected individuals can excrete 105–1011 viral particles
per gram of stool (Bosch, 1998). Since nearly 1013–1014 bacteria
are found in feces (Gill et al., 2006), viruses remain in close con-
tact with bacteria following excretion into the environment. Using
an environmental stability assay, we found that the T99K virus
had reduced viability when exposed to an environmental pres-
sure as compared to WT (Figures 6F, 6G, and 6I). These results
indicate that viral binding to bacteria or bacterial polysaccha-
rides may offer a selective advantage by enhancing environ-
mental stability.
Our work sheds light on how viruses interact with the micro-
biota in the gastrointestinal tract and in the environment. While
microbiota are predominantly located in the gut, they are also
found at numerous other sites on the human body including
the skin, respiratory tract, and urogential tract. Since most
viruses navigate one or more of these sites, interactions with
the microbiota are likely to be common. While we and others
have shown beneficial interactions for viruses with the micro-
biota (Kane et al., 2011; Kuss et al., 2011), this is not the rule
for all viruses. For example, the intestinal microbiota antagonize
rotavirus and influenza virus (Dolowy and Muldoon, 1964; Ichi-
nohe et al., 2011; Varyukhina et al., 2012). Some strains of human
norovirus bind extracellular glycans on certain strains of intesti-
nal bacteria, although whether this influences infection is unclear
(Miura et al., 2013). Future work into understanding how viruses
interact with the microbiota may inform vaccine strategies and
provide novel antiviral therapeutics.EXPERIMENTAL PROCEDURES
Viruses and Cells
Poliovirus work was performed in BSL2+ areas in accordance with practices
recommended by the World Health Organization. Poliovirus (serotype 1 viru-
lent Mahoney and serotype 1 attenuated Sabin) cell culture infections and pla-
que assays were performed using HeLa cells (Kuss et al., 2008). Construction
of mutant viruses is described in Supplemental Information.
Poliovirus Stability Assays
For titer-based stability assays, 105 pfu of poliovirus was mixed with com-
pounds and incubated at 37C or 42C. Before and after incubation, samples44 Cell Host & Microbe 15, 36–46, January 15, 2014 ª2014 Elsevier Iwere quantified by plaque assay using HeLa cells. Poliovirus titers from the
zero time point were compared to postincubation titers to determine the %
input pfu. For bleach experiments, 107 pfu Mahoney poliovirus was incubated
with compounds at 37C for 1 hr followed by treatment ±0.1 mg/L (0.001%)
bleach for 1 min. Samples were neutralized by diluting 10-fold into a solution
of 0.01% sodium thiosulfate prior to plaque assay.
For sucrose gradient assays 35S-labeled Mahoney poliovirus was prepared
and purified by CsCl gradient (Kuss et al., 2011). 35S-labeled virus (30,000
CPM) was incubated ±LPS at 42C for 1 hr prior to loading on 10%–30% su-
crose gradients with a 60%cushion. Gradients were centrifuged at 25,000 rpm
in a Fiberlite F50L-8 3 39 rotor for 1.5 hr at 4C. Fractions were collected and
scintillation counted to determine CPM. 80S gradient marker controls con-
sisted of 35S-labeled poliovirus heated at 56C for 15 min and 160S gradient
markers consisted of unheated 35S-labeled poliovirus.
For PaSTRy experiments the concentration of unlabeled CsCl-gradient
purified virus was determined by optical density at 260 nm (Arita et al., 1998;
Bibb et al., 1994). One microgram of virus was preincubated with compounds
for 1 hr at 37C. Samples weremixed with SYPRORed (33 final concentration)
or SYBR Green II (103 final concentration) and buffer (10 mMHEPES [pH 8.0],
200 mM NaCl) to a final volume of 50 ml (Walter et al., 2012). Samples were
placed in an ABI 7500 real-time instrument and heated from 25C to 99C
on a 1% stepwise gradient with fluorescence monitoring.
Poliovirus Cell Attachment and PVR Binding Assays
35S-labeled poliovirus (3,000 CPM) was exposed to compounds at 37C for
1 hr and incubated with HeLa cells or murine L929 cells at 4C for 10 min to
facilitate viral binding. Cells were washed three times with cold PBS and
trypsinized, and 35S was quantified in the scintillation counter. In Figure 2A
experiments, HeLa cells were treated ±5 mg of mouse anti-PVR/CD155 anti-
body (Santa Cruz) or mouse IgG control antibody (BioLegend) for 1 hr at
37C followed by PBS washing and addition of virus. For PVR binding exper-
iments, recombinant human PVR (R&D Systems) was spotted on a nitrocellu-
lose membrane and dried at room temperature for 1 hr. Wheat germ agglutinin
protein, in identical concentrations to PVR, was spotted onto themembrane to
control for nonspecific viral binding (data not shown). To establish a standard
curve, 35S-labeled poliovirus was quantified by scintillation counting, and
knownCPMwere also spotted to eachmembrane.Membranes were prehybri-
dized in PBS+ (PBS supplementedwith 100 mg/mlMgCl2 and 100 mg/ml CaCl2)
with 3% BSA for 1 hr at 37C. 35S-labeled virus (20,000 CPM) was exposed to
1 mg/ml LPS or PBS at 37C for 1 hr before addition to the membranes in
PBS+/3%BSA and incubated at 37C for 3 hr. Membranes were washed three
times in PBS+ and exposed to a phosphorimager screen for analysis on a
STORM 860 Molecular Imager (Molecular Devices).
Biotin-LPS Virus Pull-Down Assay
35S-labeled poliovirus (107 pfu/7,000 CPM) was mixed with biotinylated LPS
(E. coli O111:B4; Invivogen) or nonbiotinylated LPS (0127:B8; Sigma-Aldrich)
at various concentrations. To each sample, 30 ml of streptavidin agarose resin
(Thermo Scientific) was added and samples were incubated for 3 hr at 37C.
Following incubation, streptavidin agarose resin was pelleted by centrifugation
at 2,600 3 g for 2 min. Resin was washed three times with PBS+, and resin-
associated radioactivity was quantified by scintillation counting. Nonspecific
binding was subtracted using CPM from samples incubated with nonbiotiny-
lated LPS. Data are expressed as percent of input CPM (streptavidin agarose
resin associated CPM/input CPM 3 100). Prism version 6.0c was used for
nonlinear regression (curve fit) analysis using a two site binding equation.
For Figure S3 experiments, 35S-labeled poliovirus was incubated at 37C for
3 hr with 150 mg/ml biotinylated LPS, followed by incubation for 3 hr with
streptavidin agarose resin ± 1,500 mg/ml nonbiotinylated LPS, and samples
were processed as above.
Mouse Experiments
All animals were handled according to the Guide for the Care of Laboratory
Animals of the National Institutes of Health. All mouse studies were performed
at UT Southwestern (Animal Welfare Assurance #A3472-01) using protocols
approved by the local Institutional Animal Care and Use Committee in a
manner designed to minimize pain, and any animals that exhibited severe dis-
ease were euthanized immediately. C57BL/6 PVR-IFNAR/mice, expressingnc.
Cell Host & Microbe
LPS Enhancement of Poliovirus Stabilitythe human PVR and deficient for the IFNa/b receptor, were obtained from
S. Koike (Tokyo, Japan )(Ida-Hosonuma et al., 2005). Seven- to nine-week-
old PVR-IFNAR/ mice were inoculated perorally with 1 3 108 pfu of polio-
virus. Mice were euthanized upon severe disease onset, including paralysis,
encephalitis, and severe lethargy. For shedding and replication experiments,
mice were inoculated perorally with 1 3 108 pfu of standard poliovirus or
neutral red/light-sensitive poliovirus (to measure replication), and feces were
collected at indicated time points postinoculation and processed as previously
described (Kuss et al., 2011). For replication experiments, light-sensitive virus
was processed in the dark under a red safety light, and a portion was light
exposed. Light-exposed and unexposed virus was quantified by plaque assay
to determine the amount of replicating virus by dividing light-exposed pfu/ml
by light unexposed pfu/ml and multiplying by 100.
In Vivo Environmental Stability Assay
For experiments in Figures 6E–6G, WT and T99K-Nhe viruses were mixed (13
107 pfu each), and mice were inoculated perorally. Fresh feces were collected
at 6 hr postinoculation. Mice were sacrificed at 24 hr postinfection, but feces
were incubated in the cage for 24 or 96 hr at room temperature. Fecal viruses
were amplified in HeLa cells until cytopathic effects were observed and
RNA was isolated. Viruses passaged only in cell culture served as a control.
Experiments in Figures 6H and 6I were performed in a similar manner, except
that primary mouse feces were incubated in the cage for 96 hr at room
temperature, followed by viral amplification in HeLa cells and peroral inocula-
tion of naive secondary mice with 2 3 107 pfu. Feces from secondary mice
were incubated in the cage for 96 hr at room temperature, followed by viral
amplification in HeLa cells. In all cases, viral RNA was isolated with TRIzol
as per the manufacturer’s protocol (Invitrogen) and cDNA was prepared using
SuperScript II Reverse Transcriptase (Invitrogen). A 32P end-labeled (Kuss
et al., 2008) antisense oligonucleotide primer (50-GATTTAAGGCATGCC
CATTGTTAG) was used for cDNA amplification by PCR with an unlabeled
sense primer (50-TTTCGACACCCAGAGAGATGGA). RT-PCR products were
digested with NheI overnight at 37C, and bands were separated by electro-
phoresis on a denaturing 5% acrylamide gel. Bands were quantified using
phosphorimaging.
Statistical Analysis
The differences between groups were examined by two-tailed Student’s
t tests. p < 0.05 was considered statistically significant. WT and T99K mouse
survival curves were not significantly different (p > 0.05 by log rank test;
Figure 5D).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article at http://dx.doi.org/10.
1016/j.chom.2013.12.004.
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